Today: 8 February 2026
Subscribe
Browse Category

NYSE:NLY News 6 January 2026 - 11 January 2026

AGNC stock rises with mortgage REITs after Trump’s $200B MBS order — what to watch next week

AGNC stock rises with mortgage REITs after Trump’s $200B MBS order — what to watch next week

AGNC Investment Corp. closed Friday up about 2% after President Trump ordered $200 billion in mortgage bond purchases, sending housing-linked stocks higher. AGNC ended at $11.41. Traders await more details on the program and Tuesday’s U.S. CPI data. The move narrowed mortgage spreads and lifted agency MBS prices, but market reaction remains cautious.
11 January 2026
······
Rithm Capital (RITM) stock slips below $11 as rate bets shift ahead of U.S. jobs data

Rithm Capital (RITM) stock slips below $11 as rate bets shift ahead of U.S. jobs data

Rithm Capital shares fell about 1.5% to $10.99 in Tuesday morning trading, reversing Monday’s gain and moving below $11. The stock remains 14% under its 52-week high. Investors are watching Friday’s U.S. jobs report and Rithm’s early February earnings for signals on rates and dividends. The company declared a $0.25 quarterly dividend, payable Jan. 30.
6 January 2026
····

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop